Boston Scientific Corporation (FRA:BSX)
Germany · Delayed Price · Currency is EUR 88.60
+0.20 (0.23%)
Jul 22, 2025, 8:35 AM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Other | -1.00M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
MedSurg | 5.99B | Log In | Log In | Log In | Log In | Upgrade |
MedSurg Growth | 10.88% | Log In | Log In | Log In | Log In | Upgrade |
Cardiovascular | 10.76B | Log In | Log In | Log In | Log In | Upgrade |
Cardiovascular Growth | 24.48% | Log In | Log In | Log In | Log In | Upgrade |
Rhythm & Neuro | - | Log In | Log In | Log In | Log In | Upgrade |
Rhythm & Neuro Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | -1.00M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
MedSurg Income Before Taxes | - | Log In | Log In | Log In | Log In | Upgrade |
MedSurg Income Before Taxes Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Cardiovascular Income Before Taxes | - | Log In | Log In | Log In | Log In | Upgrade |
Cardiovascular Income Before Taxes Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Rhythm & Neuro Income Before Taxes | - | Log In | Log In | Log In | Log In | Upgrade |
Rhythm & Neuro Income Before Taxes Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
MedSurg Organic Revenue Growth | 7.50% | Log In | Log In | Log In | Log In | Upgrade |
Rhythm & Neuro Organic Revenue Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Cardiovascular Organic Revenue Growth | 21.90% | Log In | Log In | Log In | Log In | Upgrade |